Read more

August 12, 2021
2 min read
Save

Allergic conjunctivitis negatively impacts quality of life for children, parents

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Quality of life for children with allergic conjunctivitis was significantly lower for them and their parents compared with children without it, according to findings published in JAMA Ophthalmology.

“Although the quality of life (QOL) of patients with allergic conjunctivitis (AC) has been reported, to our knowledge, none of these studies focused on children, which is the patient population most affected by AC. In addition, these studies did not discuss whether there were any associations between AC and these patients’ parents,” Shi-yao Zhang, MD, and colleagues from Sun Yat-sen University, in Guangzhou, China, wrote.

In a prospective case-control study, Zhang and colleagues analyzed data from 92 youths aged 5 to 18 years with AC (83.7% boys) and their parents (72.8% women), in addition to 96 healthy age-matched children (57.3% girls) and their parents (79.2% women) who served as controls. The researchers observed participants at Zhongshan Ophthalmic Center from Nov. 16, 2019, through Jan. 20, 2020.

The investigators subdivided 92 participants in the AC group into cohorts with vernal keratoconjunctivitis (VKC; n = 23 [25%]) or atopic keratoconjunctivitis (AKC; n = 7 [7.6%]) and seasonal allergic conjunctivitis (SAC; n = 26 [28.3%]) or perennial allergic conjunctivitis (PAC; n = 36 [39.1%]).

Researchers used the Pediatric Quality of Life Inventory, version 4.0 (PedsQL) to evaluate scores for the children and their parents. Scores are scaled from 0 to 100, valuing the highest number as the best quality of life with the least negative aspects.

Median total PedsQL scores were lower in both children with AC (69.6 [interquartile range [IQR] = 66.3-72.8 vs. 96.7; IQR = 92.7-98.9; P < .001) and their parents (68.8; IQR = 63.9-71.4 vs. 96.5; IQR = 95.1-97.9; P < .001). However, the reduction in health-related QOL was more significant in children with VKC/AKC compared with those with SAC/PAC (difference, –3.3; 95% CI, –5.4 to –1.1) and their parents (difference, –4.3; 95% CI, –7.1 to –2.1).

Additionally, a higher corneal fluorescein staining score was associated with lower QOL in children with AC (Beta, –1.16; 95% CI, –1.8 to –0.52); higher corneal fluorescein staining scores (Beta, –1.12; 95% CI, –1.74 to –0.5) and several clinical consultations (Beta, –3.96; 95% CI, –7.34 to –0.57) correlated with reduced QOL in parents.

The parents' QOL scores were associated with their children's QOL scores (correlation coefficient, r = 0.59; P < .001).

Limitations of the study include the socioeconomic status and condition severity of each participant. Also, because an AC-specific QOL questionnaire was unavailable, participants used a questionnaire specific to allergic rhinitis and asthma instead.

“An unexpected finding was that the decrease of QOL in children with AC was worse than in previous studies of children diagnosed with blinding diseases, such as glaucoma and congenital cataract, in which the same PedsQL questionnaires had been used,” Zhang and colleagues wrote. “The findings of this study suggest a multifaceted association of allergic conjunctivitis with quality of life; detailed assessment of quality of life for improved care of pediatric patients with chronic allergic conjunctivitis would be useful.”